Publications by authors named "Dejan Bojanic"

12Publications

Impact of high-throughput screening in biomedical research.

Nat Rev Drug Discov 2011 03;10(3):188-95

Department of Sample Management Technologies, GlaxoSmithKline, Mail Stop UP 12-200, 1250S Collegeville Rd, Collegeville, Pennsylvania 19426, USA.

View Article and Find Full Text PDF
March 2011

Novel trends in high-throughput screening.

Curr Opin Pharmacol 2009 Oct 21;9(5):580-8. Epub 2009 Sep 21.

Novartis Institutes for BioMedical Research, Center of Proteomic Chemistry, Protease Platform, Novartis Campus, CH-4002 Basel, Switzerland.

View Article and Find Full Text PDF
October 2009

Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery.

J Biomol Screen 2008 Jun 12;13(5):343-53. Epub 2008 May 12.

ADME Profiling Cambridge, Metabolism and Pharmacokinetics, Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA.

View Article and Find Full Text PDF
June 2008

Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety.

Expert Opin Drug Metab Toxicol 2007 Oct;3(5):641-65

Novartis Institutes for Biomedical Research, Metabolism and Pharmacokinetics, 250 Massachusetts Avenue, Cambridge, MA 02139, USA.

View Article and Find Full Text PDF
October 2007

Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.

Drug Discov Today 2005 Nov;10(21):1421-33

PreClinical Profiling, Lead Discovery Center, Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.

View Article and Find Full Text PDF
November 2005

Handbook of Drug Screening.

Authors:
Dejan Bojanic

Drug Discov Today 2001 Dec;6(24):1266

Lead Discovery, Millennium Pharmaceuticals, 02139,. Tel.: +1-617-761-6809; fax: +1-617-374-7784, Cambridge, MA, USA

View Article and Find Full Text PDF
December 2001